Compounds > esorubicin
Page last updated: 2024-09-04

esorubicin and Thrombopenia

esorubicin has been researched along with Thrombopenia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bosia, L; Cavalli, F; Kaplan, S; Pusterla, C; Sessa, C; Varini, M1
Crespeigne, N; Kenis, Y; Rozencweig, M1
Bagatella, M; Bonardi, G; Calciati, A; Donadio, M; Giaccone, G1

Other Studies

3 other study(ies) available for esorubicin and Thrombopenia

ArticleYear
Phase I trial of 4'-deoxydoxorubicin given weekly.
    Investigational new drugs, 1984, Volume: 2, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents; Doxorubicin; Drug Evaluation; Female; Humans; Leukopenia; Male; Middle Aged; Neoplasms; Thrombocytopenia

1984
Phase I trial with 4'-deoxydoxorubicin (esorubicin).
    Investigational new drugs, 1983, Volume: 1, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents; Doxorubicin; Drug Evaluation; Female; Humans; Leukopenia; Male; Middle Aged; Neoplasms; Thrombocytopenia

1983
4'-Deoxydoxorubicin, an inactive drug in small cell lung cancer.
    European journal of cancer & clinical oncology, 1987, Volume: 23, Issue:9

    Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Small Cell; Doxorubicin; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Thrombocytopenia

1987